Trials / Completed
CompletedNCT00630968
S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in Epilepsy
Trial Studying the Safety and Efficacy of Keppra® as Adjunctive Therapy in Adult Patients With Uncontrolled Partial Epilepsy
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 1,541 (actual)
- Sponsor
- UCB Pharma · Industry
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
The purposes of the study were to obtain further information about the optimal dose and the efficacy of Keppra in daily clinical practice, and to confirm the favorable safety and tolerability profiles of the drug observed during clinical development.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Levetiracetam (Keppra) |
Timeline
- Start date
- 2000-08-01
- Primary completion
- 2004-02-01
- Completion
- 2004-02-01
- First posted
- 2008-03-07
- Last updated
- 2013-11-15
Source: ClinicalTrials.gov record NCT00630968. Inclusion in this directory is not an endorsement.